HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ME 3277

structure in first source

Also Known As:

ME3277

Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - ME 3277: 4

Experts

1.	Ishiwata, Kazuya: 1 article (04/2005)
2.	Jonker, Johan W: 1 article (04/2005)
3.	Kojima, Maho: 1 article (04/2005)
4.	Kondo, Chihiro: 1 article (04/2005)
5.	Kusuhara, Hiroyuki: 1 article (04/2005)
6.	Okudaira, Noriko: 1 article (04/2005)
7.	Onuki, Reiko: 1 article (04/2005)
8.	Sugiyama, Yuichi: 1 article (04/2005)
9.	Suzuki, Hiroshi: 1 article (04/2005)
10.	Suzuki, Michiko: 1 article (04/2005)

Related Diseases

1.	Infarction (Infarctions) 06/25/1999 - "While the same doses of ME3277 reduced the frequency of the cyclic flow reductions and increased the total patency time of the middle cerebral artery, time to thrombotic occlusion was prolonged only at the highest dose, 3 mg/kg. ME3277 (0.3-3 mg/kg) significantly reduced the infarct volume and improved the neurological deficit at 24 h. " 06/01/2000 - "At 24 hours of middle cerebral artery (MCA) occlusion, infarct volume was significantly reduced by aspirin and each dose of ME3277. "
2.	Neurologic Manifestations (Neurological Manifestations) 06/01/2000 - "These agents improved neurologic deficits, with ME3277 being more potent than aspirin. "
3.	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/01/2000 - "ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery."
4.	Cerebral Infarction 06/01/2000 - "ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery."
5.	Breast Neoplasms (Breast Cancer) 04/01/2005 - "Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2)."

Related Drugs and Biologics

1.	Aspirin (Acetylsalicylic Acid)
2.	Proteins (Proteins, Gene)
3.	Prodrugs
4.	SM 20302
5.	SDZ GPI 562